https://bioinnovationbeacon.com/ascendis-pharma-to-participate-in-the-jefferies-london-healthcare-conference/2026-11-10T21:01:00+00:00https://bioinnovationbeacon.com/lakefront-presenteert-op-de-2026-jefferies-global-healthcare-conference-in-londen/2026-11-10T21:01:00+00:00https://bioinnovationbeacon.com/lakefront-to-present-at-the-2026-jefferies-global-healthcare-conference-in-london/2026-11-10T21:01:00+00:00https://bioinnovationbeacon.com/tela-bio-reports-third-quarter-2026-financial-results/2026-11-10T21:00:00+00:00https://bioinnovationbeacon.com/exicure-inc-announces-agreement-to-sell-gpc-100-program-assets-to-gpcrt-inc-for-krw-6-5-billion/2026-11-10T20:50:00+00:00https://bioinnovationbeacon.com/capital-increase-in-genmab-as-a-result-of-employee-warrant-exercise/2026-11-10T20:32:00+00:00https://bioinnovationbeacon.com/pimjetmi-pimicotinib-developed-by-abbisko-therapeutics-and-licensed-by-merck-kgaa-darmstadt-germany-receive-u-s-fda-approval-for-tgct/2026-11-11T04:05:00+00:00https://bioinnovationbeacon.com/cullinan-therapeutics-provides-corporate-update-and-reports-third-quarter-2026-financial-results/2026-11-10T12:00:00+00:00https://bioinnovationbeacon.com/nurix-therapeutics-to-participate-in-upcoming-investor-conferences/2026-11-10T12:00:00+00:00https://bioinnovationbeacon.com/harvard-bioscience-announces-third-quarter-2026-financial-results/2026-11-10T12:00:00+00:00https://bioinnovationbeacon.com/rene-goehrum-files-early-warning-report-for-historical-ownership-positions/2026-11-10T12:00:00+00:00https://bioinnovationbeacon.com/calcimedica-reports-third-quarter-2026-financial-results-and-provides-clinical-corporate-updates/2026-11-10T12:00:00+00:00https://bioinnovationbeacon.com/sionna-therapeutics-reports-third-quarter-2026-financial-results/2026-11-10T12:00:00+00:00https://bioinnovationbeacon.com/opus-genetics-announces-financial-results-for-third-quarter-2026-and-provides-corporate-update/2026-11-10T12:00:00+00:00https://bioinnovationbeacon.com/biomea-fusion-announces-poster-presentation-of-phase-1-results-for-bmf-650-its-investigational-next-generation-oral-small-molecule-glp-1-receptor-agonist-at-obesityweek-2026/2026-11-10T12:00:00+00:00https://bioinnovationbeacon.com/ocugen-and-celairis-therapeutics-enter-into-exclusive-license-agreement-for-ocu400-in-australia-new-zealand-and-asean/2026-11-10T12:00:00+00:00https://bioinnovationbeacon.com/black-diamond-therapeutics-announces-positive-updated-silevertinib-phase-2-results-fda-feedback-supporting-a-clear-path-to-potential-registration-in-1l-egfr-ncm-nsclc-and-provides-corporate-update/2026-11-10T11:30:00+00:00https://bioinnovationbeacon.com/excelras-gostar-unterstutzt-ki-modelle-von-boltz-fur-die-wirkstoffforschung/2026-11-11T05:15:00+00:00https://bioinnovationbeacon.com/iaso-bio-announces-nmpa-ind-approval-for-iaso208-advancing-its-in-vivo-car-t-platform-into-synchronized-u-s-china-clinical-development/2026-11-11T05:02:00+00:00https://bioinnovationbeacon.com/onco-innovations-announces-agreement-to-terminate-performance-based-funding-arrangement-with-sorbie/2026-11-11T04:24:00+00:00https://bioinnovationbeacon.com/marvel-announces-final-shank3-data-mb-204-highly-effective-at-reversing-autism-behaviours/2026-11-10T11:00:00+00:00https://bioinnovationbeacon.com/elypta-announces-urine-biomarker-study-demonstrating-improved-five-year-cancer-risk-prediction-in-5436-adults/2026-11-11T07:00:00+00:00https://bioinnovationbeacon.com/hansa-biopharma-reports-third-quarter-and-interim-year-to-date-2026-financial-results/2026-11-11T06:39:00+00:00https://bioinnovationbeacon.com/hansa-biopharma-reports-third-quarter-and-interim-year-to-date-2026-financial-results-2/2026-11-11T06:37:00+00:00https://bioinnovationbeacon.com/sino-biological-treibt-die-validierung-ki-gestutzter-molekule-mit-4rise-voran/2026-11-11T09:40:00+00:00https://bioinnovationbeacon.com/ascletis-submits-ind-application-to-the-u-s-fda-for-asc30_39-fdc-a-potentially-first-in-class-oral-small-molecule-fixed-dose-combination-of-glp-1r-agonist-and-selective-amylin-receptor-agonist-for/2026-11-11T09:10:00+00:00https://bioinnovationbeacon.com/novo-commits-usd-200-million-over-10-years-to-support-the-world-diabetes-foundation-to-strengthen-diabetes-prevention-and-care/2026-11-11T09:30:00+00:00https://bioinnovationbeacon.com/genprex-to-highlight-dual-delivery-strategy-for-diabetes-gene-therapy-at-future-of-cell-and-gene-therapy-symposium/2026-11-11T12:00:00+00:00https://bioinnovationbeacon.com/viatris-to-participate-in-upcoming-investor-conferences/2026-11-11T11:59:00+00:00https://bioinnovationbeacon.com/q32-bio-to-participate-in-the-2026-jefferies-global-healthcare-conference-in-london/2026-11-11T11:59:00+00:00https://bioinnovationbeacon.com/accro-bioscience-announces-first-patient-enrolled-in-phase-ii-iii-clinical-trial-of-highly-selective-tyk2-jak1-inhibitor-ac-201-for-non-segmental-vitiligo/2026-11-11T10:39:00+00:00https://bioinnovationbeacon.com/ac-immune-to-present-at-jefferies-global-healthcare-conference-2026/2026-11-11T12:00:00+00:00https://bioinnovationbeacon.com/nurix-therapeutics-appoints-arati-v-rao-m-d-as-chief-medical-officer/2026-11-11T12:00:00+00:00https://bioinnovationbeacon.com/charm-therapeutics-and-collaborator-dr-florian-perner-to-present-compelling-data-showing-the-potential-of-next-generation-menin-inhibitors-to-deliver-more-durable-responses-for-aml-at-the-8th-ash-ann/2026-11-11T12:00:00+00:00https://bioinnovationbeacon.com/nkarta-presents-initial-safety-data-for-nkx019-in-40-patients-across-five-autoimmune-diseases-at-acr-convergence-2026/2026-11-11T12:00:00+00:00https://bioinnovationbeacon.com/cdt-commences-human-skin-studies-with-qima-life-sciences-on-novel-tapinarof-combinations-in-vitiligo/2026-11-11T12:00:00+00:00https://bioinnovationbeacon.com/sinaptica-therapeutics-to-host-scientific-symposium-at-ctad-2026-exploring-the-role-of-brain-network-dysfunction-in-alzheimers-disease/2026-11-11T12:00:00+00:00https://bioinnovationbeacon.com/whiskey-you-wont-find-on-shelves-breckenridge-distillery-launches-the-2-mile-high-whiskey-club/2026-11-11T12:00:00+00:00https://bioinnovationbeacon.com/hemab-therapeutics-to-participate-in-upcoming-investor-conferences/2026-11-11T12:00:00+00:00https://bioinnovationbeacon.com/nrx-pharmaceuticals-begins-selling-u-s-made-preservative-free-ketamine-amid-long-running-shortage/2026-11-11T12:00:00+00:00https://bioinnovationbeacon.com/the-savings-that-cost-more-new-report-puts-a-number-on-europes-innovation-choice/2026-11-11T11:05:00+00:00https://bioinnovationbeacon.com/novartis-zolgensma-woes-bios-china-plan-glp-1s-new-safety-warning-fdas-stacked-november/2026-11-11T10:44:00+00:00https://bioinnovationbeacon.com/expression-therapeutics-ceo-to-attend-45th-j-p-morgan-healthcare-conference-2027/2026-11-11T14:05:00+00:00https://bioinnovationbeacon.com/customerinsights-ai-recognized-as-2026-biotech-breakthrough-analytics-solution-provider-of-the-year/2026-11-11T14:00:00+00:00https://bioinnovationbeacon.com/nereus-the-goat-of-biscayne-bay-arrives-for-miami-art-week/2026-11-11T14:00:00+00:00https://bioinnovationbeacon.com/accelerating-biologics-programs-through-smarter-decision-making-across-the-product-life-cycle-upcoming-webinar-hosted-by-xtalks/2026-11-11T13:30:00+00:00https://bioinnovationbeacon.com/citius-pharmaceuticals-to-participate-in-the-jefferies-global-healthcare-conference-in-london/2026-11-11T13:30:00+00:00https://bioinnovationbeacon.com/caris-launches-landmark-study-to-challenge-fragmented-testing-in-myeloid-malignancies/2026-11-11T13:30:00+00:00https://bioinnovationbeacon.com/inovio-to-participate-in-upcoming-investor-conferences/2026-11-11T13:05:00+00:00https://bioinnovationbeacon.com/shanton-pharma-receives-ema-and-fda-pediatric-study-waivers-for-sap-001-in-hyperuricemia/2026-11-11T13:00:00+00:00https://bioinnovationbeacon.com/litmys-and-pharmaace-announce-strategic-collaboration-to-strengthen-commercial-forecasting-and-life-sciences-decision-making/2026-11-11T13:00:00+00:00https://bioinnovationbeacon.com/amgen-announces-positive-phase-3-results-for-dazodalibep-in-sjogrens-disease/2026-11-11T13:00:00+00:00https://bioinnovationbeacon.com/beeline-medicines-announces-presentation-of-phase-2-results-of-afimetoran-in-systemic-lupus-erythematosus-at-acr-convergence-2026/2026-11-11T14:00:00+00:00https://bioinnovationbeacon.com/23andme-research-institute-and-scripps-research-translational-institute-a-division-of-scripps-research-partner-to-bring-genetics-based-recruitment-to-alzheimers-prevention-research/2026-11-11T14:00:00+00:00https://bioinnovationbeacon.com/akari-therapeutics-participates-in-virtual-investor-what-this-means-segment-featuring-newly-appointed-chief-business-officer-vatnak-vat-ho/2026-11-11T13:44:00+00:00https://bioinnovationbeacon.com/wave-life-sciences-to-present-at-jefferies-global-healthcare-conference-in-london/2026-11-11T13:30:00+00:00https://bioinnovationbeacon.com/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london/2026-11-11T13:30:00+00:00https://bioinnovationbeacon.com/lightsolver-to-unveil-the-first-public-demonstration-of-its-all-optical-computer-at-sc26/2026-11-11T13:00:00+00:00https://bioinnovationbeacon.com/filana-therapeutics-names-biopharma-executive-jill-m-quigley-to-board/2026-11-11T13:00:00+00:00https://bioinnovationbeacon.com/five-presentations-one-leading-innovation-humacytes-acellular-tissue-engineered-vessel-takes-center-stage-at-veith-2026/2026-11-11T13:00:00+00:00https://bioinnovationbeacon.com/atyr-pharma-to-participate-in-upcoming-investor-conferences/2026-11-11T13:00:00+00:00https://bioinnovationbeacon.com/imvivabio-presents-longer-term-data-from-clinical-studies-of-cta313-allogeneic-car-t-therapy-in-lupus-at-the-american-college-of-rheumatology-convergence-2026/2026-11-11T13:00:00+00:00https://bioinnovationbeacon.com/zinzino-ab-publ-zinzino-acquires-uzesta-to-boost-distribution-capabilities-in-the-apac-region/2026-11-11T15:04:00+00:00https://bioinnovationbeacon.com/helixs-research-access-program-offers-clinicogenomic-data-access-to-a-select-group-of-academic-researchers/2026-11-11T14:15:00+00:00https://bioinnovationbeacon.com/research-solutions-announces-agreement-with-fortune-500-biopharma-company-valued-at-1-million/2026-11-11T13:00:00+00:00https://bioinnovationbeacon.com/shanton-pharma-receives-ema-and-fda-pediatric-study-waivers-for-sap-001-in-hyperuricemia-2/2026-11-11T13:00:00+00:00https://bioinnovationbeacon.com/immunofoco-presents-a-novel-in-vivo-tce-delivery-strategy-using-lentiviral-vectors-at-sitc-2026/2026-11-11T12:52:00+00:00https://bioinnovationbeacon.com/metagenomi-therapeutics-inc-to-present-at-the-jefferies-global-healthcare-conference-in-london/2026-11-11T13:00:00+00:00https://bioinnovationbeacon.com/lycia-therapeutics-to-present-at-the-2026-jefferies-global-healthcare-conference/2026-11-11T12:30:00+00:00https://bioinnovationbeacon.com/dyne-therapeutics-to-participate-in-upcoming-investor-conference/2026-11-11T12:30:00+00:00https://bioinnovationbeacon.com/teva-shares-innovative-pipeline-updates-and-unveils-path-to-future-growth-at-rd-day-targeting-6-7-billion-in-innovative-medicines-revenue-by-2030/2026-11-11T12:30:00+00:00https://bioinnovationbeacon.com/polypid-provides-corporate-update-and-reports-third-quarter-2026-financial-results/2026-11-11T12:30:00+00:00https://bioinnovationbeacon.com/applied-biologics-announces-research-collaboration-with-dartmouth-college-focused-on-computational-protein-engineering/2026-11-11T12:24:00+00:00https://bioinnovationbeacon.com/capricor-parts-ways-with-10-of-staff-as-fda-decision-on-dmd-cell-therapy-nears/2026-11-11T15:15:00+00:00https://bioinnovationbeacon.com/capricor-ramps-up-manufacturing-spend-ahead-of-fda-decision-for-dmd-therapy/2026-11-11T15:00:00+00:00https://bioinnovationbeacon.com/transformative-biotech-welcomes-nicholas-meyerson-phd/2026-11-11T15:10:00+00:00https://bioinnovationbeacon.com/energy-drinks-linked-to-11-times-more-reports-of-cardiac-arrest/2026-11-11T13:10:00+00:00https://bioinnovationbeacon.com/pepgen-shares-almost-double-as-dm1-oligonucleotide-achieves-best-in-class-splicing/2026-11-11T15:23:00+00:00